# Filing Detail

Form 10-Q - Quarterly report [Sections 13 or 15(d)]:
SEC Accession No. 0001493152-25-021069
Filing Date
2025-11-06
Accepted
2025-11-06 16:07:39
Documents
53
Period of Report
2025-09-30

Document Format Files

Seq | Description | Document | Type | Size
--- | --- | --- | --- | ---
1 | 10-Q | form10-q.htm iXBRL | 10-Q | 730501
2 | EX-31.1 | ex31-1.htm | EX-31.1 | 12938
3 | EX-31.2 | ex31-2.htm | EX-31.2 | 12810
4 | EX-32.1 | ex32-1.htm | EX-32.1 | 11934
5 | GRAPHIC | form10-q_001.jpg | GRAPHIC | 52972
| Complete submission text file | 0001493152-25-021069.txt |  | 4234050

Data Files

Seq | Description | Document | Type | Size
--- | --- | --- | --- | ---
6 | XBRL SCHEMA FILE | pcsa-20250930.xsd | EX-101.SCH | 35766
7 | XBRL CALCULATION FILE | pcsa-20250930_cal.xml | EX-101.CAL | 33946
8 | XBRL DEFINITION FILE | pcsa-20250930_def.xml | EX-101.DEF | 158171
9 | XBRL LABEL FILE | pcsa-20250930_lab.xml | EX-101.LAB | 312237
10 | XBRL PRESENTATION FILE | pcsa-20250930_pre.xml | EX-101.PRE | 254891
55 | EXTRACTED XBRL INSTANCE DOCUMENT | form10-q_htm.xml | XML | 503253

Mailing Address 601 21ST STREET, SUITE 300 VERO BEACH FL 32960
Business Address 601 21ST STREET, SUITE 300 VERO BEACH FL 32960 443-776-3133
Processa Pharmaceuticals, Inc. (Filer) CIK: 0001533743 (see all company filings)

EIN.: 451539785 | State of Incorp.: DE | Fiscal Year End: 1231
Type: 10-Q | Act: 34 | File No.: 001-39531 | Film No.: 251458258
SIC: 2834 Pharmaceutical Preparations
(CF Office: 03 Life Sciences)